Eclipta prostrata L. phytochemicals: Isolation, structure elucidation, and their antitumor activity
Authors:
- Hai-Yan ZhaoHZHai-Yan Zhao
- Xian-Ke ZhongXZXian-Ke Zhong
- Jian-Guo JiangJJJian-Guo Jiang
- 1 November 2012
- journal article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 50 (11) , 4016-4022
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inhibition of topoisomerase IIα: Novel function of wedelolactoneCancer Letters, 2011
- Antiinflammatory Constituents from Eclipta prostrata using RAW264.7 Macrophage CellsPhytotherapy Research, 2011
- Extraction optimisation of daphnoretin from root bark of Wikstroemia indica (L.) C.A. and its anti-tumour activity testsFood Chemistry, 2011
- Cytoprotective effect of Proanthocyanidin‐rich cranberry fraction against bacterial cell wall‐mediated toxicity in macrophages and epithelial cellsPhytotherapy Research, 2009
- Anticancer-cytotoxic activity of saponins isolated from the leaves ofGymnema sylvestreandEclipta prostrataon HeLa cellsInternational Journal of Green Pharmacy, 2009
- Inhibition of Proteolytic and Hemorrhagic Activities by Ethyl Acetate Extract ofEclipta prostrata. Against Malayan Pit Viper VenomPharmaceutical Biology, 2007
- Analgesic studies on total alkaloids and alcohol extracts of Eclipta alba (Linn.) Hassk.Phytotherapy Research, 2004
- Trypsin inhibitory effect of wedelolactone and demethylwedelolactonePhytotherapy Research, 2003
- Studies on the Constituents of Compositae Plants. Part II. Oleanane Glycosides from Eclipta alba.Chemical and Pharmaceutical Bulletin, 1994
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989